(Hypertension. 2000;35:775.)
© 2000 American Heart Association, Inc.
Scientific Contributions |
Effect of Calcium Antagonists on Glomerular Arterioles in Spontaneously Hypertensive Rats
From the Section of Human Anatomy, Departments of Pharmacological Sciences and Experimental Medicine (M.S., F.A.) and Comparative Morphology and Biochemical Sciences (L.V.), University of Camerino, Camerino, Italy; and Pharmaceutical Research and Development (A.L., R.T.), Recordati Industria Chimica e Farmaceutica SpA, Milan, Italy.
Correspondence to Francesco Amenta, MD, Dipartimento di Scienze Farmacologiche e Medicina Sperimentale, via M Scalzino 3, 62032 Camerino, Italy. E-mail amenta{at}cambio.unicam.it
Abstract—Through the use of microanatomic techniques, we investigated the effects of treatment with some dihydropyridine-type calcium antagonists (CAs) (ie, lercanidipine, manidipine, and nicardipine) and with the nondihydropyridine-type vasodilator hydralazine on hypertension-dependent glomerular injury and on the morphology of afferent and efferent arterioles in spontaneously hypertensive rats (SHR). Fourteen-week-old male SHR and age-matched normotensive Wistar-Kyoto rats were left untreated (control groups). Four additional groups of 14-week-old SHR were treated for 12 weeks with daily oral doses of 2.5 mg/kg lercanidipine, 5 mg/kg manidipine, 3 mg/kg nicardipine, or 10 mg/kg hydralazine. These treatments decreased systolic blood pressure values to a similar extent in SHR. Signs of glomerular injury, as characterized by glomerulosclerosis, hypertrophy, and an increased number of mesangial cells, were observed in control SHR. The treatment with CAs improved glomerular morphology and decreased the number of mesangial cells. Lercanidipine and manidipine were more effective than nicardipine in countering glomerular injury. In the SHR, both afferent and efferent arterioles revealed luminal narrowing, accompanied by increased wall thickness in efferent arterioles. The dihydropyridine-type derivatives that were tested decreased the luminal narrowing of afferent arterioles. Lercanidipine and manidipine countered the luminal narrowing of efferent arterioles. Hydralazine had no effect on hypertension-dependent glomerular injury or vascular changes. The present data indicate that lercanidipine and manidipine vasodilate afferent and efferent arterioles in SHR. A vasodilatory activity on efferent arteriole, which is not induced by the majority of CAs, may represent an useful property in the treatment of hypertension complicated by renal disease.
Key Words: calcium antagonists • arterioles • rats, SHR
This article has been cited by other articles:
 |
|
 |
|
  Y.-G. Sun, Y.-X. Cao, W.-W. Wang, S.-F. Ma, T. Yao, and Y.-C. Zhu Hydrogen sulphide is an inhibitor of L-type calcium channels and mechanical contraction in rat cardiomyocytes Cardiovasc Res, September 1, 2008; 79(4): 632 - 641. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Rosenthal, E. Rosenmann, D. Tomassoni, and F. Amenta Effect of Lercanidipine on Kidney Microanatomy in Cohen-Rosenthal Diabetic Hypertensive Rats Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2007; 12(2): 145 - 152. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Sabbatini, L. Vitaioli, E. Baldoni, and F. Amenta Nephroprotective Effect of Treatment with Calcium Channel Blockers in Spontaneously Hypertensive Rats J. Pharmacol. Exp. Ther., September 1, 2000; 294(3): 948 - 954. [Abstract] [Full Text]
|
|